Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Using a quadruple polypill to prevent major CV events

Although CV disease is the main cause of death globally, it is a particularly significant issue in developing countries where there are more challenges to accessing medication. One solution to this issue has been a multi-drug polypill to simplify prescriptions and improve adherence. The first large scale study of this approach recently published five year results showing the polypill reduced the risk of major CV events by a third in Iran, suggesting the suitability and efficacy of this approach.


Go Top